Skip to main content
. 2021 May;9(9):804. doi: 10.21037/atm-21-1994

Table 3. MIA clinicopathological features.

Variable Total (n=107) Group 1 (MIA <1 cm) (n=82) Group 2 (MIA ≥1 cm) (n=25) P value
Multiple primary lung cancer (n) 50 (46.7%) 36 (43.9%) 14 (56%) 0.289
Clinical tumor size (cm) 9.36±3.508 [3–26] 8.05±1.962 [3–14] 13.64±4.051 [8–26] <0.001*
Pathological tumor size (cm) 8.94±3.685 [3–25] 7.29±1.718 [3–10] 14.36±3.817 [11–25] <0.001*
Size change (n) 17 (15.9) 10 (12.2%) 7 (28%) 0.069
CT density change (n) 7 (6.5%) 5 (6.1%) 2 (8%) 0.664
CT image (n) 0.785
   pGGO 41 (38.3%) 32 (39%) 9 (36%)
   mGGO 66 (61.7%) 50 (61%) 16 (64%)
CT density (average) −433.50±173.876 −419.56±182.795 −479.24±133.845 0.134
Surgical procedure (n) 0.011*
   Wedge resection 43 (40.2%) 38 (46.3%)       5 (20%)
   Segmentectomy 26 (24.3%) 21 (25.6%)       5 (20%)
   Lobectomy 38 (35.5%) 23 (28.1%)       15 (60%)

Data are presented as mean (SD), range [–] or n (%). *P<0.05. MIA, minimally invasive adenocarcinoma; CT, computed tomography; pGGO, pure ground-glass opacity; mGGO, mixed solidity ground glass opacity; SD, standard deviation.